Anti Xa for Heparin Infusion
General Information
Lab Name
Anti Xa for Heparin Infusion
Lab Code
HIXA
Epic Name
Anti-Xa for Unfractionated Heparin
Description
Anti-Xa for Heparin Infusion (HIXA) is used to monitor heparin concentration in patients treated with unfractionated heparin.
HIXA results will be falsely elevated in the presence of direct factor Xa inhibitors (such as apixaban, rivaroxaban, edoxaban) or low molecular weight heparin.
Synonyms
Anti 10A, Anti Factor X, AntiXa, Factor 10A, HEPACT, Heparin Activity, Heparin Level, Unfractionated Heparin
Interpretation
Method
This method determines a factor Xa inhibitor level by measuring the inhibition of factor Xa cleavage of a chromogenic substrate. Because no exogenous antithrombin is added in this assay, and because antithrombin plays a significant role in factor Xa inhibition with heparin, low molecular weight heparin or fondaparinux, patients with lower antithrombin levels (<70%) may demonstrate lower anti-Xa activity.
Reference Range
Units: IU/mL
Ref. Range Notes
Regular Intensity Heparin Therapy: 0.3-0.7 IU/mL
Low Intensity Heparin Therapy: 0.3-0.5 IU/mL
For more information, visit UW Medicine Anticoagulation Services
Interferences and Limitations
HIXA results will be falsely elevated in the presence of direct factor Xa inhibitors (such as apixaban, rivaroxaban, edoxaban) or low molecular weight heparin.
Low antithrombin level (<70%) may cause an underestimation of the heparin level.
This assay is insensitive to hemoglobin (up to 0.15 g/dL), conjugated bilirubin (up to 28.8 mg/dL), unconjugated bilirubin (up to 13.8 mg/dL), and triglycerides (up to 690 mg/dL).
Ordering & Collection
Specimen Type
Collection
4.5 mL BLUE TOP (CITRATE) tube or 2.7 mL BLUE TOP (CITRATE) Tube or 1.8mL "Light" BLUE TOP (Citrate) tube
Handling Instructions
Specimen must be processed/centrifuged within one hour of collection. After initial centrifugation the test is viable on samples up to 4 hours old. If testing cannot be done within 4 hours, remove and re-spin plasma, decant upper layer of plasma and freeze until testing can be performed.
Sodium citrate samples at UW-NW must be centrifuged within one hour and are stable at room temperature up to 2 hours. If there is a delay greater than 1 hour, re-spin plasma, remove upper layer of plasma and freeze until testing can be performed.
Outside Laboratories: Within one hour of collection, centrifuge sample for 10 minutes, remove plasma & re-spin for another 10 minutes. Remove upper layer of plasma and freeze (1 mL) @ -20 ˚C to - 80 ˚C. Transport frozen on dry ice.
Note: Samples that are drawn through a heparinized line may be contaminated by the heparin in the line. HIXA results on this sample would reflect the anti-Xa activity of the heparin in the patient as well as the heparin from the line and may be erroneously increased.
Samples containing platelet clumps or hemolysis due to difficult blood draws may show decreased heparin activity due to in vitro platelet activation. If results are unexpectedly low, redraw the sample and repeat the test.
Quantity
requested: 1.0 mL citrated plasma
minimum: 0.5 mL citrated plasma
Processing
Take whole blood specimen to COAG Lab
For HIXA as add-on test to previous sample, check with coag testing bench personnel to determine if testing can be performed due to specimen stability or volume issues
Performance
LIS Dept Code
Coagulation (COAG)
Performing Location(s)
HMC |
Coagulation
206-520-4600 325 9th Ave, Rm # GWH-47, Seattle, WA 98104-2420 |
|
---|---|---|
UW-NW |
Main Lab
206-668-1344 UW Medical Center – Northwest |
|
UW-MT |
Coagulation
206-520-4600 Clinical Lab, Room NW220, |
Frequency
Daily, performed as received
Available STAT?
Yes
Billing & Coding
CPT codes
85520
LOINC
Interfaced Order Code
UOW2729
Interfaced Result Code
UOW2729